Summit Therapeutics Inc (NASDAQ:SMMT) stock is trading 181.15 percent above its 52-week low
Stifel raised the price target for the Summit Therapeutics Inc (NASDAQ:SMMT) stock to “a Buy”. The rating was released on March 26, 2024, according to finviz. The stock was reiterated by Needham, who disclosed in a research note on April 12, 2018, to Buy and set the price objective to $27. In their research brief […]
What is Summit Therapeutics Inc’s (SMMT) Stock Real Technical Picture?
Stifel raised the price target for the Summit Therapeutics Inc (NASDAQ:SMMT) stock to “a Buy”. The rating was released on March 26, 2024, according to finviz. The stock was reiterated by Needham, who disclosed in a research note on April 12, 2018, to Buy and set the price objective to $27. In their research brief […]
Stay away from Summit Therapeutics Inc (SMMT) Stock or get into it
Stifel raised the price target for the Summit Therapeutics Inc (NASDAQ:SMMT) stock to “a Buy”. The rating was released on March 26, 2024, according to finviz. The stock was reiterated by Needham, who disclosed in a research note on April 12, 2018, to Buy and set the price objective to $27. In their research brief […]
Summit Therapeutics Inc (NASDAQ:SMMT) Stock is trading at a margin of -5.30% From 20-Day SMA
Stifel raised the price target for the Summit Therapeutics Inc (NASDAQ:SMMT) stock to “a Buy”. The rating was released on March 26, 2024, according to finviz. The stock was reiterated by Needham, who disclosed in a research note on April 12, 2018, to Buy and set the price objective to $27. In their research brief […]
The future of Summit Therapeutics Inc (SMMT) Stock is still in tatters?
Stifel raised the price target for the Summit Therapeutics Inc (NASDAQ:SMMT) stock to “a Buy”. The rating was released on March 26, 2024, according to finviz. The stock was reiterated by Needham, who disclosed in a research note on April 12, 2018, to Buy and set the price objective to $27. In their research brief […]
A New Look at Summit Therapeutics Inc (SMMT) Stock’s Hidden Strategies
Janney raised the price target for the Summit Therapeutics Inc (NASDAQ:SMMT) stock from “a Buy” to “a Neutral”. The rating was released on June 28, 2018, according to finviz. The research report from Needham has reiterated the stock to Buy, with a price target set at $27. The stock was initiated by BTIG Research, who […]
Will Earnings Beat Estimates? Summit Therapeutics Inc (SMMT) Stock
Janney raised the price target for the Summit Therapeutics Inc (NASDAQ:SMMT) stock from “a Buy” to “a Neutral”. The rating was released on June 28, 2018, according to finviz. The research report from Needham has reiterated the stock to Buy, with a price target set at $27. The stock was initiated by BTIG Research, who […]
What does the future hold for Summit Therapeutics Inc (SMMT) Stock?
Janney raised the price target for the Summit Therapeutics Inc (NASDAQ:SMMT) stock from “a Buy” to “a Neutral”. The rating was released on June 28, 2018, according to finviz. The research report from Needham has reiterated the stock to Buy, with a price target set at $27. The stock was initiated by BTIG Research, who […]
